EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Vergleichsstudie

Comparison, Agreement, and Significance Cutoffs of 18 F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages

René R Sevag Packard, Christopher Buckley, C David Cooke, Jonathan B Moody, Jennifer M Renaud, Piotr Slomka, David Thompson, Serge D Van Kriekinge, Kenneth F Van Train, Kristen A Wangerin, Jamshid Maddahi

Journal of Nuclear Medicine · 2025-11 · 66 (11) · 1674-1682

DOI: 10.2967/jnumed.124.269398 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 07.08.2025. Verfasst von René R Sevag Packard und 10 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, UCLA, Los Angeles, California; rpackard@mednet.ucla.edu. Hauptthemen laut MEDLINE: Aminopyridines, Coronary Circulation, Myocardial Perfusion Imaging, Positron-Emission Tomography. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminopyridinesCoronary CirculationMyocardial Perfusion ImagingPositron-Emission TomographyPyridazinesSoftwareAgedFemaleHumansMaleMiddle Aged

Stichwörter der Autor:innen

flurpiridazhumanmyocardial blood flowpositron emission tomographyquantitation method

Substanzen

AminopyridinesBMS 747158-02Pyridazines

Autor:innen und Institutionen

  • David Geffen School of Medicine, UCLA, Los Angeles, California; rpackard@mednet.ucla.edu.
  • Pharmaceutical Diagnostics, GE HealthCare, Chalfont St. Giles, United Kingdom.
  • Syntermed, Atlanta, Georgia.
  • INVIA, Ann Arbor, Michigan; and.
  • Cedars-Sinai Medical Center, Los Angeles, California.
  • David Geffen School of Medicine, UCLA, Los Angeles, California.

Zitieren

APA

Packard, R. R. S., Buckley, C., Cooke, C. D., Moody, J. B., Renaud, J. M., Slomka, P., Thompson, D., Van Kriekinge, S. D., Van Train, K. F., Wangerin, K. A., & Maddahi, J. (2025). Comparison, Agreement, and Significance Cutoffs of 18 F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages. Journal of Nuclear Medicine, 66(11), 1674-1682. https://doi.org/10.2967/jnumed.124.269398

Vancouver

Packard RRS, Buckley C, Cooke CD, Moody JB, Renaud JM, Slomka P, et al. Comparison, Agreement, and Significance Cutoffs of 18 F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages. Journal of Nuclear Medicine. 2025;66(11):1674-1682. doi:10.2967/jnumed.124.269398

BibTeX
@article{Packard2025,
  author = {Packard, René R Sevag and Buckley, Christopher and Cooke, C David and Moody, Jonathan B and Renaud, Jennifer M and Slomka, Piotr and Thompson, David and Van Kriekinge, Serge D and Van Train, Kenneth F and Wangerin, Kristen A and Maddahi, Jamshid},
  title = {Comparison, Agreement, and Significance Cutoffs of 18 F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  volume = {66},
  number = {11},
  pages = {1674--1682},
  doi = {10.2967/jnumed.124.269398}
}
Kostenlos starten →